Postpartum anemia II: Prevention and treatment

Annals of Hematology

Volumn 91, Issue 2, 2012, Pages 143-154

  Milman, Nils ^a  

^a NAESTVED HOSPITAL   (Denmark)

Author keywords

Anemia, Iron deficiency; EPO protein, Human; Hemoglobins; Iron; Iron i.v.; Postpartum hemorrhage; Postpartum period; Pregnancy

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRIC HYDROXIDE SUCROSE; FERRIC ION; FERRIC IRON ISOMALTOSIDE; FERRITIN; FERROUS ION; FERROUS SULFATE; HEMOGLOBIN; IRON DEXTRAN; IRON POLYMALTOSE; MONOFER; RECOMBINANT ERYTHROPOIETIN; UNCLASSIFIED DRUG;

ANEMIA; BLOOD TRANSFUSION; COGNITIVE DEFECT; DEVELOPING COUNTRY; DIAGNOSTIC TEST; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; ERYTHROPOIESIS; FATIGUE; FERRITIN BLOOD LEVEL; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEALTH PROGRAM; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFECTION; INFLAMMATION; INTRAPARTUM HEMORRHAGE; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON DEPLETION; IRON INTAKE; IRON STORAGE; IRON THERAPY; LACTATION; MATERNAL CARE; MATERNAL DISEASE; MATERNAL WELFARE; MENTAL DISEASE; NUTRITIONAL REQUIREMENT; PHYSICAL DISABILITY; POSTPARTUM ANEMIA; POSTPARTUM HEMORRHAGE; PREGNANCY COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PUERPERIUM; REVIEW; RISK ASSESSMENT; TREATMENT CONTRAINDICATION; TREATMENT DURATION;

ANEMIA; CLINICAL TRIALS AS TOPIC; DEVELOPING COUNTRIES; FEMALE; HUMANS; IRON; IRON, DIETARY; POSTPARTUM HEMORRHAGE; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 84857361317     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1381-2     Document Type: Review

References (73)

1. N Milman 2011 Postpartum anemia I: definition, prevalence, causes and consequences Ann Hematol 90 1247 1253 21710167 10.1007/s00277-011-1279-z
2. Milman N. Anemia-still a major health problem in many parts of the world! Ann Hematol 2011; 90:369-377. http://dx.doi.org/ 10.1007/s00277-010-1144-5
3. World Health Organization (1999) Reduction of maternal mortality. A joint WHO/UNFPA/UNICEF/World Bank statement. World Health Organization, Geneva
4. M Potts M Campbell 2004 Three meetings and fewer funerals: misoprostol in postpartum hemorrhage Lancet 364 1110 1111 15451208 10.1016/S0140-6736(04) 17120-1 (Pubitemid 39296590)
5. VD Tsu B Shane 2004 New and underutilized technologies to reduce maternal mortality: call to action from a Bellagio workshop Int J Gynecol Obstet 85 Suppl 1 S83 S93 10.1016/j.ijgo.2004.02.011 (Pubitemid 38625921)
6. LM Bodnar AM Siega-Riz WC Miller ME Cogswell T McDonald 2002 Who should be screened for postpartum anemia? An evaluation of current recommendations Am J Epidemiol 156 903 912 12419762 10.1093/aje/kwf134 (Pubitemid 35304070)
7. RL Bergmann R Richter KE Bergmann JW Dudenhausen 2010 Prevalence and risk factors for early postpartum anemia Eur J Obstet Gynecol Reprod Biol 150 126 131 20303210 10.1016/j.ejogrb.2010.02.030
8. N Milman M Kirchhoff 1992 Iron stores in 1359, 30- to 60-year-old Danish women: evaluation by serum ferritin and hemoglobin Ann Hematol 64 22 227 1739756 10.1007/BF01811467 1:STN:280:DyaK387ltl2gsA%3D%3D
9. N Milman 2008 Prepartum anaemia: prevention and treatment Ann Hematol 87 949 959 18641987 10.1007/s00277-008-0518-4 1:CAS:528:DC%2BD1cXht1OisLjM
10. Y Oyelese CV Ananth 2010 Postpartum hemorrhage: epidemiology, risk factors, and causes Clin Obstet Gynecol 53 147 156 20142652 10.1097/GRF. 0b013e3181cc406d
11. Danish Society for Obstetrics and Gynaecology http://www.dsog.dk
12. N Milman OA Agger OJ Nielsen 1991 Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo controlled study in 207 Danish women Dan Med Bull 38 471 476 1802636 1:STN:280:DyaK383gtFSjsQ%3D%3D
13. A Åkesson P Bjellerup M Berglund K Bremme M Vahter 2002 Soluble transferrin receptor: longitudinal assessment from pregnancy to postlactation Obstet Gynecol 99 260 266 11814507 10.1016/S0029-7844(01)01684-2 (Pubitemid 34113999)
14. World Health Organization. Iron deficiency anemia. Assessment, prevention and control. 2001;WHO/NHD/01.3
15. N Milman T Bergholt L Eriksen K-E Byg N Graudal P Pedersen J Hertz 2005 iron prophylaxis during pregnancy-how much iron is needed? A randomised, controlled study of 20 to 80 mg ferrous iron daily to pregnant women Acta Obstet Gynecol Scand 84 238 247 15715531 (Pubitemid 40333103)
16. N Milman 2006 Iron and pregnancy-a delicate balance Ann Hematol 85 559 565 16691399 10.1007/s00277-006-0108-2 1:CAS:528:DC%2BD28XosFWktbs%3D (Pubitemid 44283075)
17. TH Bothwell 2000 Iron requirements in pregnancy and strategies to meet them Am J Clin Nutr 72 257S 264S 10871591 1:CAS:528:DC%2BD3cXkslOktbg%3D (Pubitemid 30439797)
18. MA Siimes E Vuori P Kuitunen 1979 Breast milk iron-a declining concentration during the course of lactation Acta Paed Scand 68 29 31 10.1111/j.1651-2227.1979.tb04425.x 1:CAS:528:DyaE1MXjslSktw%3D%3D (Pubitemid 9018893)
19. Pedersen AN, Fagt S, Groth MV, Christensen T, Biltoft-Jensen, Matthiessen J, et al. Dietary habits in Denmark 2003-2008. Main results: National Food Agency of Denmark. 2010
20. Commission of the European Communities. Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food. Directorate General Industry 1993;31st series:180-181
21. National Collaborating Centre for Women's & Children's Health. NICE Clinical Guideline 62-Antenatal Care; March 2008
22. Social-og helsedirektoratet. Retningslinjer for svangerskapsomsorgen. www.shdir.no/publikasjoner Accessed December 2008
23. CDC Recommendations 1998 to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention MMWR Recomm Rep 47 1 29
24. International Food information Council Foundation. Healthy eating during pregnancy. www.foodinsight.org Accessed January 2009
25. www.altomkost.dk Accessed January 2010
26. www.meraadet.dk Accessed March 2008
27. Swedish Society for Obstetrics and Gynecology. Maternal health, sexual and reproductive health (Mödrahälsovård, sexuell och reproduktiv hälsa) 2008;rapport no. 59:47-48
28. K Trygg K Lund-Larsen B Sandstad HJ Hoffman G Jacobsen LS Bakketeig 1995 Do pregnant smokers eat differently from pregnant non-smokers? Paediatr Perinat Epidemiol 9 307 319 7479279 10.1111/j.1365-3016.1995.tb00147.x 1:STN:280:DyaK28%2FmtFajsA%3D%3D
29. Nordic Council of Ministers. Nordic Nutrition Recommendations 2004. Copenhagen 2004
30. N Milman K-E Byg T Bergholt L Eriksen A-M Hvas 2006 Body iron and individual iron prophylaxis in pregnancy-should the iron dose be adjusted according to serum ferritin? Ann Hematol 85 567 573 16733739 10.1007/s00277-006-0141-1 1:CAS:528:DC%2BD28XosFWktbk%3D (Pubitemid 44283076)
31. N Milman 2006 Iron prophylaxis in pregnancy-general or individual and in which dose? Ann Hematol 85 821 828 16763841 10.1007/s00277-006-0145-x 1:CAS:528:DC%2BD28XhtVyqtrjP (Pubitemid 44594206)
32. Breymann C, Honegger C, Holzgreve W, Surbek D. Diagnostik und Therapie der Anämie in der Schwangerschaft und postpartal. Schweizerische Gesellschaft für Gynäkologie und Geburtshilfe. Expertenbrief 2007 no. 22
33. Beris P, Maniatis A, on behalf of the NATA working group on intravenous iron therapy. Guidelines on intravenous iron supplementation in surgery and obstetrics/gynecology. Transfusion Alternatives in Transfusion Medicine 2007;9 Suppl 1:29
34. ACOG Practice Bulletin 2006 clinical management guidelines for obstetrician/gynecologists number 76, 2006: postpartum hemorrhage Obstet Gynecol 108 1039 1047 10.1097/00006250-200610000-00046
35. L Royal College of Obstetricians and Gynaecologist, Green top Guidelines, November 2009 http://www.rcog.org.uk/files/rcog-corp/Green- top52PostpartumHaemorrhage.pdf
36. PV Rajan DA Wing 2010 Postpartum hemorrhage: evidence-based medical interventions for prevention and treatment Clin Obstet Gynecol 53 165 181 20142654 10.1097/GRF.0b013e3181ce0965
37. Russell RT. WHO guidelines for the management of postpartum haemorrhage and retained placenta. World Health Organization WHO Press, Geneva, Switzerland, 2009, ISBN 978-92-4-159851-4
38. S Dar IS Vardi G Holcberg H Reuveni R Yerushalmi M Katz E Sheiner 2006 Do we need routine complete blood count following vaginal delivery? Int J Fertil Womens Med 51 270 273 17566570 (Pubitemid 46786880)
39. Recommendation to prevent and control iron deficiency in the United States. MMWR Morb Mortal Wkly Rep 1998; 47(RR-3):13-25
40. Dodd JM, Dare MR, Middleton P. Treatment for women with postpartum iron deficiency anemia. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD004222. DOI: 10.1002/14651858.CD004222.pub2
41. Skikne B, Baynes RD (1994) Iron absorption. In: Brock JH, Halliday JW, Pippard MJ, Powell LW (eds) iron metabolism in health and disease. Saunders, London, pp 151-187
42. N Milman N Graudal OJ Nielsen AO Agger 1997 Serum erythropoietin during normal pregnancy: relationship to hemoglobin and iron status markers and impact of iron supplementation in a longitudinal, placebo-controlled study on 118 women Int J Hematol 66 159 168 9277046 10.1016/S0925-5710(97)00031-5 1:CAS:528:DyaK2sXmtVGms70%3D (Pubitemid 27360179)
43. A Krafft C Breymann 2011 Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study J Obstet Gynaecol Res 37 119 124 21159035 10.1111/j.1447-0756.2010.01328.x 1:CAS:528:DC%2BC3MXisVGms74%3D
44. JB Nielsen E Ikkala L Sölvell E Björn-Rasmussen G Ekenved 1976 Absorption of iron from slow-release and rapidly-disintegrating tablets-a comparative study in normal subjects, blood donors and subjects with iron deficiency anemia Scand J Haematol Suppl 28 89 97 1064905 1:STN:280: DyaE283isVWntA%3D%3D
45. Venofer®. Summary of Product Characteristics www.medicines.org.uk Accessed February 6th 2011
46. CosmoFer®. Summary of Product Characteristics www.medicines.org.uk Accessed February 6th 2011
47. Ferinject®. Summary of Product Characteristics www.medicines.org.uk Accessed February 6th 2011
48. KA Lyseng-Williamson GM Keating 2009 Ferric carboxymaltose: a review of its use in iron-deficiency anemia Drugs 69 739 756 19405553 10.2165/00003495- 200969060-00007 1:CAS:528:DC%2BD1MXnvFaitLg%3D
49. Monofer®. Summary of Product Characteristics www.medicines.org.uk Accessed February 6th 2011
50. AK al-Momen A al-Meshari L al-Nuaim A Saddique Z Abotalib T Khashogji, et al. 1996 Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy Eur J Obstet Gynecol Reprod Biol 69 121 124 8902444 10.1016/0301-2115(95)02538-3 1:CAS:528:DyaK28XmvFKkurw%3D (Pubitemid 26338317)
51. A al-Ragip E Unlubilgin O Kandemir S Yalvac L Cakir A Haberal 2005 Intravenous versus oral iron for treatment of anemia in pregnancy: a randomized trial Obstet Gynecol 106 1335 1340 10.1097/01.AOG.0000185260.82466.b4 1:STN:280:DC%2BD28%2FktFCruw%3D%3D (Pubitemid 41668954)
52. M Hallak A Sharon R Duikman R Auslender H Abramovici 1997 Supplementation iron intravenously in pregnancy. A way to avoid blood transfusions J Reprod Med 42 99 103 9058345 1:STN:280:DyaK2s3htFentQ%3D%3D (Pubitemid 27097634)
53. C Breymann E Visca R Huch A Huch 2001 Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy Am J Obstet Gynecol 184 662 667 11262469 10.1067/mob.2001. 111717 1:CAS:528:DC%2BD3MXjtVequ7o%3D (Pubitemid 32234981)
54. A Bashiri E Burstein E Sheiner M Mazor 2003 Anemia during pregnancy and treatment with intravenous iron: review of the literature Eur J Obstet Gynecol Reprod Biol 110 2 7 12932861 10.1016/S0301-2115(03)00113-1 1:CAS:528: DC%2BD3sXmsVKgs7k%3D (Pubitemid 37025688)
55. DB Van Wyck MG Martens MH Seid JB Baker A Mangione 2007 Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia. A randomised controlled trial Obstet Gynecol 110 267 278 17666600 10.1097/01.AOG.0000275286.03283.18 (Pubitemid 47356650)
56. C Breymann C Richter C Hüttner R Huch A Huch 2000 Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anemia and blunted erythropoiesis Eur J Clin Invest 30 154 161 10651841 10.1046/j.1365-2362.2000.00605.x 1:CAS:528:DC%2BD3cXht1aku7k%3D (Pubitemid 30079574)
57. N Bhandal R Russell 2006 Intravenous versus oral iron therapy for postpartum anemia BJOG 113 1248 1252 17004982 10.1111/j.1471-0528.2006.01062.x 1:CAS:528:DC%2BD28Xht1Oks7zE (Pubitemid 44581513)
58. C Giannoulis A Daniilidis T Tantanasis K dinas J Tzafettas 2009 Intravenous administration of iron sucrose for treating anemia in postpartum women Hippokratia 13 38 40 19240819 1:STN:280:DC%2BD1M7msVGktQ%3D%3D
59. MH Seid RJ Derman JB Baker W Banach C Goldberg R Rogers 2008 Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial Am J Obst Gynecol 199 435e1 435e7 10.1016/j.ajog.2008.07.046
60. S Westad B Backe KÅ Salvesen J Nakling I Okland I Borthen, et al. 2008 A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia Acta Obstet Gynecol Scand 87 916 923 18720044 10.1080/00016340802317802 1:CAS:528:DC%2BD1cXhtlaksbfN
61. AM Ganzoni 1972 Totalinfusion von Ferri-Kohlenhydrat-Komplexen (Total infusion of ferri-carbohydrate complexes) Blut 25 349 351 4641719 10.1007/BF01632758 1:STN:280:DyaE3s%2FmtlSnug%3D%3D
62. Swedish Dental and Pharmaceutical Benefits Agency http://www.tlv.se/in- english Accessed February 6th 2011
63. AC Kotto-Kome DA Calhoun R Montenegro R Sosa L Maldonado RD Christensen 2004 Effect of administering recombinant erythropoietin to women with postpartum anemia: a meta-analysis J Perinatol 24 11 15 14726931 10.1038/sj.jp.7211017 1:CAS:528:DC%2BD2cXkt1Oltg%3D%3D (Pubitemid 38159796)
64. E Wågström A Åkesson M Van Rooijen B Larson K Bremme 2007 Erythropoietin and intravenous iron therapy in postpartum anemia Acta Obstet Gynecol Scand 86 957 962 17653881 10.1080/00016340701446157 (Pubitemid 47123611)
65. A Lebrecth f Häberlin J Eberhard 1995 Anämie im Wochenbett; parenterale Eisensubstitution macht Erythropoietin-Therapie entberlich (Postpartum anaemia; intravenous iron supplementation renders therapy with rhEPO redundant) Geburtshilfe Frauenheilkd 55 167 170 10.1055/s-2007-1022798
66. c Breymann R Zimmermann A Huch 1996 Use of recombinant erythropoietin in combination with parenteral iron in the treatment of postpartum anemia Eur J Clin Invest 26 123 130 8904521 10.1046/j.1365-2362.1996.109261.x 1:CAS:528:DyaK28Xhs1Kjsbs%3D (Pubitemid 26064615)
67. G Macrydimas G Lolis G Lialios S Tsiara I Georgiou KL Bourantas 1998 Recombinant human erythropoietin treatment of postpartum anemia. Preliminary results Eur J Obstet Gynecol Reprod Biol 81 27 31 10.1016/S0301-2115(98)00158-4 (Pubitemid 28464438)
68. C Gyamfi RL Berkowitz 2007 Management of pregnancy in a Jehova's Witness Obs Gynecol Clin N Am 34 357 365 10.1016/j.ogc.2007.06.005 (Pubitemid 47503682)
69. HF Bunn 2009 End run about Epo New Engl J Med 361 1901 1903 19890135 10.1056/NEJMe0908186 1:CAS:528:DC%2BD1MXhtl2jurjP
70. CL Roberts JB Ford JF Thomson JM Morris 2008 Population rates of hemorrhage and transfusions among obstetric patients in NSW: a short communication Aust N Z J Obstet Gynaecol 48 481 484 19032664 10.1111/j.1479-828X.2008.00910.x
71. I Al-Zirqi S Vangen L Forsen B Stray-Pedersen 2008 Prevalence and risk factors of severe obstetric hemorrhage BJOG 115 1265 1272 18715412 10.1111/j.1471-0528.2008.01859.x 1:STN:280:DC%2BD1crjs1eisw%3D%3D
72. DJ Rouse C MacPherson M Landon MW Varner KJ Leveno AH Moawad, et al. 2006 Blood transfusion and cesarean delivery Obstet Gynecol 108 891 897 17012451 10.1097/01.AOG.0000236547.35234.8c (Pubitemid 44498250)
73. AJ Fuller BA Bucklin 2010 Blood product replacement for postpartum hemorrhage Clin Obstet Gynecol 53 196 208 20142656 10.1097/GRF.0b013e3181cc42a0